JESSICA MORALES: Open Payments
NPI 1811332182 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 130 payments from 19 companies in 2025. Trend: 2023 $1,666 · 2024 $2,307 · 2025 $2,757
Food & beverage: $2,657Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $599 |
| Janssen Biotech, Inc. | 11 | $271 |
| GENZYME CORPORATION | 8 | $255 |
| Arcutis Biotherapeutics, Inc. | 17 | $234 |
| ABBVIE INC. | 13 | $195 |
| Amgen Inc. | 8 | $157 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $156 |
| Galderma Laboratories, L.P. | 8 | $149 |
| Novartis Pharmaceuticals Corporation | 8 | $136 |
| Incyte Corporation | 5 | $109 |
Products named: Bimzelx, DUPIXENT, TREMFYA, Zoryve, SKYRIZI, OTEZLA, Winlevi, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
